Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pathology of the Eisenmenger syndrome and primary pulmonary hypertension.

× No keyword cloud information.

8 in total

1. Beraprost therapy in children with pulmonary hypertension secondary to congenital heart disease.

Authors: A Limsuwan; P Pienvichit; P Khowsathit
Journal: Pediatr Cardiol Date: 2005 Nov-Dec Impact factor: 1.655

2. Effects of inhaled iloprost on congenital heart disease with Eisenmenger syndrome.

Authors: Song I Yang; Wook Jin Chung; Sung Hwan Jung; Deok Young Choi
Journal: Pediatr Cardiol Date: 2012-02-18 Impact factor: 1.655

3. Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease.

Authors: S C Apostolopoulou; A Manginas; D V Cokkinos; S Rammos
Journal: Heart Date: 2005-03-10 Impact factor: 5.994

4. Functional status of patients with large ventricular septal defect and pulmonary vascular disease 6 to 16 years after surgical closure of their defect in childhood.

Authors: K A Hallidie-Smith; R S Wilson; A Hart; E Zeidifard
Journal: Br Heart J Date: 1977-10

5. Quantitative structural analysis of pulmonary vessels in isolated ventricular septal defect in infancy.

Authors: A Hislop; S G Haworth; E A Shinebourne; L Reid
Journal: Br Heart J Date: 1975-10

6. Hemodynamic effects of nifedipine and oxygen in children with pulmonary hypertension.

Authors: M Wimmer; M Schlemmer; F Ebner
Journal: Cardiovasc Drugs Ther Date: 1988-12 Impact factor: 3.727

7. Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL).

Authors: Ioana R Preston; Kari E Roberts; Dave P Miller; Ginny P Sen; Mona Selej; Wade W Benton; Nicholas S Hill; Harrison W Farber
Journal: Circulation Date: 2015-10-28 Impact factor: 29.690

8. Survival benefits of oral anticoagulants in patients with pulmonary arterial hypertension: Protocol for a systematic review and meta-analysis.

Authors: Hai-Chao Zhang; Na Wang; Wen Zhang; Zhi-Chun Gu; Xiao-Yan Liu
Journal: Medicine (Baltimore) Date: 2018-09 Impact factor: 1.817

8 in total